Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuebijing for critically ill COVID-19 patients (EICU, APACHE II ≥18)
ChiCTR2300078398Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Feb 2023
- Countries
- 1
01
Overview
Phase 4 trial of xuebijing in coronavirus disease 2019 (COVID-19) and critical illness (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Change in viral load (CT value) between Day 1 and Day 7. Started Feb 2023; status: recruiting.
02
Drugs
xuebijing
03
Conditions
coronavirus disease 2019 (COVID-19)critical illness
Beyond the preview
Go deeper on ChiCTR2300078398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078398.